General Capillary to Arterial Endothelial Cell Transition in Pulmonary Arterial Hypertension
General Capillary to Arterial Endothelial Cell Transition in Pulmonary Arterial Hypertension
批准号:
10716738
负责人:
Zhiyu Dai
金额:
$72.17万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-15 至 2027-06-30
关键词:
ArteriesBlood VesselsBlood capillariesCapillary Endothelial CellCessation of lifeDataDevelopmentDiseaseEndothelial CellsFailureHeart HypertrophyHumanHypertensionLesionLungPathogenesisPatientsProgressive DiseasePulmonary Vascular ResistanceResearchRodentSOX17 geneSignal Transductioneffective therapymortalitynovel therapeutic interventionprematureprogramspulmonary arterial hypertensionpulmonary vascular remodelingtherapeutically effectivetreatment strategy
中文摘要
标题:肺动脉中总毛细血管向动脉内皮细胞的转变
高血压
项目摘要
肺动脉高压(PAH)的特征是肺组织进行性增加。
血管阻力和闭塞性肺血管重塑导致右心肥厚,
失败和过早死亡。毛细血管内皮细胞(ECs)和血管内皮细胞丢失的机制
闭塞性血管病变的形成仍不清楚。我们的初步数据显示动脉
程序化在人类PAH患者和啮齿动物中很明显。我们假设一般的毛细血管内皮细胞
通过HIF-2、-CDK19/Sox17/Notch4信号通路调节动脉内皮细胞
PAH的发病机制。完成我们建议的研究将提供一种新的治疗策略
对PAH患者的有效治疗。
英文摘要
Title: General Capillary to Arterial Endothelial Cell Transition in Pulmonary Arterial
Hypertension
Project Summary
Pulmonary arterial hypertension (PAH) is characterized by a progressive increase of pulmonary
vascular resistance and obliterative pulmonary vascular remodeling that result in right heart hypertrophy,
failure, and premature death. The underlying mechanisms of loss of capillary endothelial cells (ECs) and
obliterative vascular lesion formation remain unclear. Our preliminary data showed that arterial
programing was evident in human PAH patients and rodents. We hypothesize that general capillary ECs
program to arterial ECs through HIF-2-Cdk19/Sox17/Notch4 signaling which contributes to the
pathogenesis of PAH. Completing our proposed study will provide a novel therapeutic strategy for the
effective treatment of PAH in patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel alveolar mechanisms of hypoxemia in hepatopulmonary syndrome
-
批准号:10718446
-
项目类别:
-
资助金额:$76.28万
-
财政年份:2023
-
负责人:Zhiyu Dai
-
依托单位:
Fatty acid-binding proteins sustain endothelial glycolysis and arterial programming in pulmonary arterial hypertension
-
批准号:10657101
-
项目类别:
-
资助金额:$57.58万
-
财政年份:2023
-
负责人:Zhiyu Dai
-
依托单位:
Role of Endothelial SOX17 Deficiency in the Pathogenesis of Pulmonary Hypertension
-
批准号:10442975
-
项目类别:
-
资助金额:$47.98万
-
财政年份:2022
-
负责人:Zhiyu Dai
-
依托单位:
Role of Endothelial SOX17 Deficiency in the Pathogenesis of Pulmonary Hypertension
-
批准号:10594936
-
项目类别:
-
资助金额:$47.98万
-
财政年份:2022
-
负责人:Zhiyu Dai
-
依托单位:
Role of Smooth Muscle Progenitor Cells in Obliterative Vascular Remodeling and PH
-
批准号:10228636
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2019
-
负责人:Zhiyu Dai
-
依托单位:
Role of Smooth Muscle Progenitor Cells in Obliterative Vascular Remodeling and PH
-
批准号:10001625
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2019
-
负责人:Zhiyu Dai
-
依托单位:
Role of Smooth Muscle Progenitor Cells in Obliterative Vascular Remodeling and PH
-
批准号:9371373
-
项目类别:
-
资助金额:$13.26万
-
财政年份:2017
-
负责人:Zhiyu Dai
-
依托单位:
海外基金